ProShare Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$323K Sell
34,775
-6,543
-16% -$60.7K ﹤0.01% 1397
2025
Q1
$303K Sell
41,318
-9,952
-19% -$72.9K ﹤0.01% 1406
2024
Q4
$438K Buy
51,270
+12,669
+33% +$108K ﹤0.01% 1356
2024
Q3
$336K Buy
38,601
+13,552
+54% +$118K ﹤0.01% 1388
2024
Q2
$171K Sell
25,049
-3,449
-12% -$23.6K ﹤0.01% 1565
2024
Q1
$259K Buy
28,498
+10,194
+56% +$92.8K ﹤0.01% 1524
2023
Q4
$81.6K Buy
18,304
+2,985
+19% +$13.3K ﹤0.01% 1806
2023
Q3
$48.1K Buy
15,319
+153
+1% +$480 ﹤0.01% 1719
2023
Q2
$78.3K Buy
15,166
+758
+5% +$3.91K ﹤0.01% 1733
2023
Q1
$75.9K Sell
14,408
-1,876
-12% -$9.89K ﹤0.01% 1630
2022
Q4
$45.8K Buy
16,284
+1,298
+9% +$3.65K ﹤0.01% 1747
2022
Q3
$62K Buy
14,986
+353
+2% +$1.46K ﹤0.01% 1637
2022
Q2
$59K Sell
14,633
-7,683
-34% -$31K ﹤0.01% 1684
2022
Q1
$111K Sell
22,316
-5,216
-19% -$25.9K ﹤0.01% 2009
2021
Q4
$192K Buy
27,532
+1,347
+5% +$9.39K ﹤0.01% 2047
2021
Q3
$262K Sell
26,185
-7,409
-22% -$74.1K ﹤0.01% 1641
2021
Q2
$476K Buy
33,594
+3,709
+12% +$52.6K ﹤0.01% 1576
2021
Q1
$490K Buy
29,885
+3,669
+14% +$60.2K ﹤0.01% 1454
2020
Q4
$543K Buy
+26,216
New +$543K ﹤0.01% 1220
2019
Q4
Sell
-17,500
Closed -$53K 1798
2019
Q3
$53K Buy
17,500
+1,220
+7% +$3.7K ﹤0.01% 1597
2019
Q2
$72K Sell
16,280
-1,609
-9% -$7.12K ﹤0.01% 1557
2019
Q1
$71K Buy
17,889
+444
+3% +$1.76K ﹤0.01% 1596
2018
Q4
$69K Buy
+17,445
New +$69K ﹤0.01% 1512
2016
Q4
Sell
-17,423
Closed -$120K 1748
2016
Q3
$120K Sell
17,423
-3,200
-16% -$22K ﹤0.01% 1404
2016
Q2
$102K Buy
20,623
+614
+3% +$3.04K ﹤0.01% 1521
2016
Q1
$193K Sell
20,009
-2,069
-9% -$20K ﹤0.01% 1432
2015
Q4
$207K Buy
+22,078
New +$207K ﹤0.01% 1522